Safe discharge from the cardiac emergency room with a rapid rule-out myocardial infarction protocol using serial

R Bholasingh1, R J de Winter, J C Fischer

  • 1Department of Cardiology, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, Netherlands. r.bholasingh@amc.uva.nl

Insights

A new protocol using a rapid creatine kinase-MB (CK-MB) mass assay can safely rule out myocardial infarction in chest pain patients, significantly reducing emergency room stays.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Biomarker Assays

Background:

  • Chest pain is a common emergency room presentation requiring accurate diagnosis of myocardial infarction.
  • Traditional diagnostic protocols can lead to prolonged emergency room stays.
  • Creatine kinase-MB (CK-MB) assays are crucial for diagnosing myocardial infarction.

Purpose of the Study:

  • To evaluate a new protocol for ruling out myocardial infarction (MI) in chest pain patients.
  • To assess if a rapid CK-MB (mass) assay and serial sampling can decrease emergency room length of stay.
  • To determine if this protocol can be implemented without increasing patient risk.

Main Methods:

  • A comparative study was conducted between patients managed with a CK-MB (activity) assay in 1994 and those managed with a rapid CK-MB (mass) assay in 1996.
  • Patients were discharged from the cardiac emergency room after ruling out MI.
  • Combined incidence of cardiac death and acute MI at 30 days, 6 months, and 24 months was compared.

Main Results:

  • The median length of stay in the cardiac emergency room was significantly reduced from 16.0 hours in 1994 to 9.0 hours in 1996 (p < 0.0001).
  • Mean event rates (cardiac death or MI) at 30 days, 6 months, and 24 months showed no significant difference between the two groups.
  • Kaplan-Meier survival analysis confirmed no difference in event-free survival between the cohorts.

Conclusions:

  • A protocol utilizing a rapid and sensitive CK-MB (mass) assay with serial sampling can effectively rule out myocardial infarction in chest pain patients.
  • This protocol significantly reduces the length of stay in the cardiac emergency room.
  • The implementation of this protocol does not compromise patient safety.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...